Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.94 - $2.56 $22,654 - $61,696
-24,100 Reduced 26.81%
65,800 $64,000
Q2 2022

Aug 15, 2022

SELL
$1.78 - $5.02 $22,250 - $62,749
-12,500 Reduced 12.21%
89,900 $172,000
Q1 2022

May 13, 2022

BUY
$3.54 - $8.08 $362,496 - $827,392
102,400 New
102,400 $509,000
Q2 2021

Aug 12, 2021

SELL
$13.81 - $23.25 $138,100 - $232,500
-10,000 Closed
0 $0
Q4 2020

Feb 03, 2021

SELL
$12.83 - $17.84 $16,679 - $23,192
-1,300 Reduced 11.5%
10,000 $166,000
Q1 2020

May 06, 2020

BUY
$10.74 - $16.32 $121,362 - $184,416
11,300 New
11,300 $131,000

Others Institutions Holding HARP

About Harpoon Therapeutics, Inc.


  • Ticker HARP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,106,800
  • Description
  • Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...
More about HARP
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.